Aixin Shi

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Placebo Controlled

Top Venues

Diabetes, obesity & metabolism

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Panpan Xie, Morten T Abildlund, Tine A Baekdal, Xuemei He, Yassine K Lyauk, Usha Rani H Patted, Zu Ning, Aixin Shi
A phase 1, randomized, double-blind, placebo-controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects. Diabetes, obesity & metabolism 26 (8) (2024)
Panpan Xie, Morten T Abildlund, Tine A Baekdal, Xuemei He, Yassine K Lyauk, Usha Rani H Patted, Zu Ning, Aixin Shi
A phase 1, randomized, double-blind, placebo-controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects. Diabetes, obesity & metabolism 26 (8) (2024)
Panpan Xie, Morten T Abildlund, Tine A Baekdal, Xuemei He, Yassine K Lyauk, Usha Rani H Patted, Zu Ning, Aixin Shi
A phase 1, randomized, double-blind, placebo-controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects. Diabetes, obesity & metabolism (2024)
Aixin Shi, Panpan Xie, Lasse Lykke Nielsen, Trine Vang Skjøth, Xuemei He, Sine Pfeiffer Haugaard
Pharmacokinetics, Safety and Tolerability of Once-Weekly Subcutaneous Semaglutide in Healthy Chinese Subjects: A Double-Blind, Phase 1, Randomized Controlled Trial. Advances in therapy 38 (1) (2020)